Document text
Principal Investigator: Lovick Edward Cannon
Organization: NOVAB, INC.
Fiscal Year: 2021
Award: $256,506
Funding agency: National Institute of Allergy and Infectious Diseases
PROJECT SUMMARY
There is an urgent need to rapidly detect SARS-CoV-2 (CoV-2) virus in clinical and nonclinical settings, including
point of care sites, workplace, and home, at sensitivity and specificity comparable or superior to RT-PCR
detection of CoV-2 RNA. Much of the person-to-person CoV-2 transmission occurs before infected individuals
develop symptoms. This significant pre-symptomatic/asymptomatic reservoir of CoV-2 transmission mandates
efficient identification of infected individuals and their contacts at population-wide screening scale to prevent
outbreaks of Covid-19 disease while allowing societies to open and economies to recover. This level of
surveillance will also be needed to fully evaluate the effectiveness of countermeasures, including vaccines and
therapies. We will develop a new class of diagnostic product reagents, antibody polymers, to create products
that can be produced and used at population screening scale for rapid CoV-2 antigen detection at significantly
improved sensitivity that approaches the sensitivity of :gold-standard” RT-PCR detection of CoV-2 genomic RNA.
Our antibody polymers will be produced by engineering a novel class of small, stable, single polypeptide anti-
CoV-2 antibodies termed variable lymphocyte receptors (VLRs) as polymers to achieve essentially irreversible
binding to CoV-2 virus. VLR polymers are compatible with all diagnostic immunoassay forms, including lateral
flow assay (LFA) “dipsticks”, which is likely to be preferred in non-laboratory settings, and with established
signaling modalities, e.g., colloidal gold and horseradish peroxidase (HRP). VLRs, the antigen receptors of
jawless vertebrates (lamprey and hagfish), are composed of highly diverse leucine-rich repeat domains and are
the only known antigen-specific immune receptors that are not immunoglobulins (Igs). The binding site of VLRs
is contained within a small single polypeptide and comprised by amino acid residues in the rigid beta-sheets that
form the concave surface of the VLR structure. The over 500 million year evolutionary separation of jawed and
jawless vertebrates and distinctive antigen-binding site structure of VLR antibodies have proved a source of
novel specificities distinct from conventional Ig antibodies. The outer envelope of the CoV-2 virus is composed
of a multivalent array of spike (S) protein that is an ideal target(s) for multivalent, essentially irreversible binding,
by appropriately multivalent binding agents. We will genetically link in tandem genes encoding VLRs with binding
specificity for CoV-2 S protein to create such multivalent VLR polymer binding agents that couple binding of CoV-
2 antigens to an amplifiable, visually observable result, e.g., color change. The high ratio of CoV-2 S protein 50
– 100 S protein trimers per virus particle, to the single copy CoV-2 RNA genome, and the amplification available
via catalysis, e.g., HRP, provides significantly improved CoV-2 antigen detection sensitivity that approaches
sensitivity achieved with RT-PCR detection of single copy CoV-2 RNA.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Amino Acids><Antibodies><Antigen Receptors><Antigens><Antisera><Behavioral><Beta Sheet><Binding><Binding Sites><Biomedical Research><COVID-19><COVID-19 detection><COVID-19 outbreak><COVID-19 virus><COVID19><COVID19 detection><COVID19 outbreak><COVID19 virus><CV-19><CV19><Caring><Catalysis><Cell Communication and Signaling><Cell Signaling><Cellulose Nitrate><Clinical><CoV-2><CoV2><Colloidal Gold><Color><Combining Site><Coupled><Detection><Diagnostic><Diagnostic Reagent><Disease><Disorder><Engineering><Epidemiology><Fc Receptor><Genes><Genome><Gold><Gold Colloid><Hagfish><Home><Horseradish Peroxidase><Human><Immune><Immune Sera><Immunes><Immunize><Immunoassay><Immunologic Receptors><Immunological Receptors><Individual><Infection><Intracellular Communication and Signaling><Jaw><Job Location><Job Place><Job Setting><Job Site><Lamprey Eels><Lampreys><Leucine-Rich Repeat><Libraries><Link><Lymphatic cell><Lymphocyte><Lymphocytic><Manufacturer><Manufacturer Name><Modality><Modern Man><Molecular Interaction><Nitrocellulose><Non-Polyadenylated RNA><Persons><Petromyzontidae><Phase><Polymers><Population><Proteins><Pyroxylin><RNA><RNA Gene Products><RT-PCR><RTPCR><Reactive Site><Reagent><Receptor Gene><Receptor Protein><Research><Reverse Transcriptase Polymerase Chain Reaction><Ribonucleic Acid><Right-Handed Beta-Alpha Superhelix><SARS corona virus 2><SARS-CoV-2><SARS-CoV-2 detection><SARS-CoV-2 outbreak><SARS-CoV2><SARS-CoV2 outbreak><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><SBIR><Sensitivity and Specificity><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 outbreak><Severe acute respiratory syndrome related corona virus 2><Signal Transduction><Signal Transduction Systems><Signaling><Site><Small Business Innovation Research><Small Business Innovation Research Grant><Societies><Solid><Source><Specificity><Structure><Surface><Symptoms><Transmission><Vaccines><Vertebrate Animals><Vertebrates><Virion><Virus><Virus Particle><Work Location><Work Place><Work-Site><Workplace><Worksite><Wuhan coronavirus><Yeasts><aminoacid><antibody receptor><antigen based detection><antigen binding><antigen bound><antigen detection><assess effectiveness><base><beta pleated sheet><biological signal transduction><communicable disease transmission><community planning><corona virus disease 2019><coronavirus disease 2019><coronavirus disease 2019 detection><coronavirus disease 2019 outbreak><coronavirus disease 2019 virus><cost><detect COVID-19><detect COVID19><detect SARS-CoV-2><detect antigen><detect severe acute respiratory syndrome coronavirus 2><detection sensitivity><determine effectiveness><disease control><disease transmission><disorder control><effectiveness assessment><effectiveness evaluation><epidemiologic><epidemiological><evaluate effectiveness><genomic RNA><hCoV19><immune receptor><immune serum><immunogen><improved><infectious disease transmission><lateral flow assay><lateral flow test><lymph cell><nCoV2><novel><phase 2 study><phase II study><point of care><polypeptide><prevent><preventing><rapid detection><receptor><reverse transcriptase PCR><screening><severe acute respiratory syndrome coronavirus 2 detection><transmission process><vertebrata><viral RNA><viral detection><virus RNA><virus detection><work setting><β-Sheet><β-pleated sheet>